Abstract

Prokineticin-2 (Prok2) is an important secreted protein likely involved in the pathogenesis of several acute and chronic neurological diseases through currently unidentified regulatory mechanisms. The initial mechanical injury of neurons by traumatic brain injury triggers multiple secondary responses including various cell death programs. One of these is ferroptosis, which is associated with dysregulation of iron and thiols and culminates in fatal lipid peroxidation. Here, we explore the regulatory role of Prok2 in neuronal ferroptosis in vitro and in vivo. We show that Prok2 prevents neuronal cell death by suppressing the biosynthesis of lipid peroxidation substrates, arachidonic acid-phospholipids, via accelerated F-box only protein 10 (Fbxo10)-driven ubiquitination, degradation of long-chain-fatty-acid-CoA ligase 4 (Acsl4), and inhibition of lipid peroxidation. Mice injected with adeno-associated virus-Prok2 before controlled cortical impact injury show reduced neuronal degeneration and improved motor and cognitive functions, which could be inhibited by Fbxo10 knockdown. Our study shows that Prok2 mediates neuronal cell deaths in traumatic brain injury via ferroptosis.

Prokineticin-2 (Prok2) is a secreted protein involved in many physiological processes. Here, the authors show that Prok2 prevents neuronal cell ferroptosis after traumatic brain injury and its administration before cortical injury reduces neuronal degeneration, and motor and cognitive impairments.

Details

Title
Prokineticin-2 prevents neuronal cell deaths in a model of traumatic brain injury
Author
Bao Zhongyuan 1 ; Liu, Yinlong 2 ; Chen, Binglin 1 ; Miao Zong 1 ; Tu Yiming 1 ; Li, Chong 1 ; Chao Honglu 1 ; Ye Yangfan 1 ; Xu Xiupeng 1 ; Sun Guangchi 1 ; Zhao Pengzhan 1 ; Liu, Ning 1 ; Liu, Yan 3   VIAFID ORCID Logo  ; Wang, Xiaoming 4   VIAFID ORCID Logo  ; Lam, Sin Man 5 ; Kagan, Valerian E 6   VIAFID ORCID Logo  ; Bayır Hülya 7   VIAFID ORCID Logo  ; Ji Jing 1   VIAFID ORCID Logo 

 the First Affiliated Hospital of Nanjing Medical University, Department of Neurosurgery, Nanjing, China (GRID:grid.412676.0) (ISNI:0000 0004 1799 0784) 
 the Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Department of Neurosurgery, Suzhou, China (GRID:grid.440227.7) (ISNI:0000 0004 1758 3572) 
 Nanjing Medical University, Institute for Stem Cell and Neural Regeneration, School of Pharmacy, Nanjing, China (GRID:grid.89957.3a) (ISNI:0000 0000 9255 8984) 
 Nanjing Medical University, Department of Immunology, Nanjing, China (GRID:grid.89957.3a) (ISNI:0000 0000 9255 8984) 
 LipidALL Technologies Company Limited, Changzhou, China (GRID:grid.511275.5) 
 University of Pittsburgh, Center for Free Radical and Antioxidant Heath, Department of Environmental and Occupational Health, Pittsburgh, USA (GRID:grid.21925.3d) (ISNI:0000 0004 1936 9000); IM Sechenov Moscow State Medical University, Laboratory of Navigational Redox Lipidomics, Moscow, Russian Federation (GRID:grid.448878.f) (ISNI:0000 0001 2288 8774) 
 University of Pittsburgh, Center for Free Radical and Antioxidant Heath, Department of Environmental and Occupational Health, Pittsburgh, USA (GRID:grid.21925.3d) (ISNI:0000 0004 1936 9000); University of Pittsburgh, Safar Center for Resuscitation Research, Department of Critical Care Medicine, Pittsburgh, USA (GRID:grid.21925.3d) (ISNI:0000 0004 1936 9000); UPMC Children’s Hospital of Pittsburgh, Children’s Neuroscience Institute, Pittsburgh, USA (GRID:grid.239553.b) (ISNI:0000 0000 9753 0008) 
Publication year
2021
Publication date
2021
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2549835487
Copyright
© The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.